NCM ยท Price History

Curanex Pharmaceuticals Inc (CURX) Price History & Returns

$4.64 NCM: CURX Market Cap $7.28M

How Curanex Pharmaceuticals Inc (CURX) has performed, year by year and over each trailing period. Price history only โ€” total return to a shareholder would also include dividends.

The share price of $4.64 sits 8% of the way up a 52-week range of $3.58 to $16.94; 72.6% below the 52-week high; a beta of -2.57 means it has historically moved opposite the market.

Total return

Price change over each trailing period, not annualised.

PeriodReturn
3 months-49.0%
6 months-36.1%
1 year+0.0%
3 years+0.0%
5 years+0.0%

Year by year

0 of 1 years closed higher than the year before. Closes are the last observation in each calendar year.

YearCloseChange
2026$4.64-29.9%

Monthly closing prices

The last 15 months, newest first. 4 of 14 months closed higher than the month before. Each figure is the last close in that month.

MonthCloseChange
October 2026$4.64-7.8%
September 2026$5.03+17.0%
August 2026$4.30+4.9%
July 2026$4.10-22.6%
June 2026$5.30-20.4%
May 2026$6.66-20.1%
April 2026$8.34-18.4%
March 2026$10.22+13.6%
February 2026$9.00+38.9%
January 2026$6.48-2.1%
December 2025$6.62-32.0%
November 2025$9.74-28.2%
October 2025$13.56-5.8%
September 2025$14.40-87.1%
August 2025$112.00โ€”

Curanex Pharmaceuticals Inc (CURX) price history โ€” frequently asked questions

How has Curanex Pharmaceuticals Inc performed over the last year?

Curanex Pharmaceuticals Inc (CURX) has risen 0.0% over the last twelve months, measured on price alone.

What is Curanex Pharmaceuticals Inc's five-year return?

Over five years the CURX share price has gained 0.0%, excluding dividends.

What is Curanex Pharmaceuticals Inc's 52-week range?

Over the last year Curanex Pharmaceuticals Inc (CURX) has traded between $3.58 and $16.94.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.